Skip to main content
Internal Medicine
ALL Specialities
ALL Specialities
/
Internal Medicine
CME
COVID-19 Updates
Diseases & Conditions
Asthma
Diabetes
Musculoskeletal Disorders
Obesity
Pain
Rare Diseases
Subspecialties
Addiction Medicine
Adolescent Medicine
Cardiology
Critical Care
Dermatology
Endocrinology
Gastroenterology
Geriatrics
Hematology
Hepatology
Hospice & Palliative Medicine
Immunology
Infectious Diseases
Men's Health
Mental Health
Nephrology
Neurology
Oncology
Pulmonology
Rheumatology
Sleep Medicine
Transgender Health
Women's Health
Multimedia
Audio
Podcasts
Video
Business of Medicine
News
EASL: Mortality and CV burden increase with NAFLD severity
Publish date:
May 4, 2015
AT THE INTERNATIONAL LIVER CONGRESS 2015
References
*A correction was made to this sentence on 5/22/2015.
Pages
« first
1
2
Recommended Reading
Novel agent lowers LDL more than ezetimibe
MDedge Internal Medicine
Prehospital mechanical CPR doesn’t improve survival
MDedge Internal Medicine
Testosterone therapy has neutral cardiovascular effects
MDedge Internal Medicine
CVD risk persists for 40 years in Hodgkin’s survivors
MDedge Internal Medicine
TRACE-RA: Statin therapy may prevent CVD in RA
MDedge Internal Medicine
Statin use associated with reduced lung cancer mortality
MDedge Internal Medicine
B cell marker may predict relapse and guide re-treatment in ANCA-AAV
MDedge Internal Medicine
Consider LDL-C and HDL-C when estimating CV risk in RA
MDedge Internal Medicine
Applications expand for vorapaxar in cardiovascular prevention
MDedge Internal Medicine
ILC: Statins linked to better outcomes in hepatitis C cirrhosis
MDedge Internal Medicine
Cardiology
Gastroenterology
Infectious Diseases
All Specialties
